Saw this interesting post on immunotherapy in the Financial Times in the waiting room.
Go to ft.com/pharmaceuticals
There was also an article: « Drugmakers take an unorthodox route to cancer biosimilars »
about the NHS buying Chinese biosimilar version, which they call « copycat » of Rituximab, Trastuzumab marketed as Herceptin, Bevacizumab marketed as Avastin.
So the chief pharmacist at the Royal Marsden is achieving savings etc..
I wish we were in the business of saving lives..
I don’t like generics maybe I am shortsighted still 😃
r u ok its me helen your friend who has that address.tell me
if u are not madame ps I like that song edif piaff sings she had a tragic life.
she had Algerian blood in her I like both la vie en rose and the sad one regrets
no life in pink 4 some people on this board is there mon amie?
Hi Fran Biologics and biosimilars are also used for autoimmune diseases like Ra or Vasculitis. I have both and many others like me depend on biosimilars like Truxima (Rituximab) . As far as Vasculitis (and cancer) are concerned, they are life saving drugs. They have been passed by NICE, and save the NHS thousands of pounds.
in reply to
Thank you for the info 😊
We have Sirolimus for LAM, which I suffer from, it was a cancer drug in the first place..which is why I was interested in the article, and the outcome..
Methotrexate was also a cancer drug originally but is a DMARD and not a biologic. As far as I know, they haven't created a cheaper copy of it yet.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.